ArticleFrontiers in medicine2025

COVID-19 inactivated booster vaccines elicit strong protection against SARS-CoV-2 wild-type and Omicron variant in patients with breast cancer.

Xiaomeng Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.